Tag: finasteride
SIGN UP FOR OUR NEWS LETTER


Quick Search

Reset

Avodart (dutasteride) & Proscar (finasteride)

Fri 1 Oct 2010

By: Mark Scholz, M.D. Prostate Oncology Specialists October 2010 Avodart® and Proscar® are FDA approved for the treatment of benign prostatic hyperplasia (BPH), the natural enlargement of the prostate that occurs with aging.  They are well-tolerated agents, except for occasional impotence or reduced libido that resolves when the treatment is stopped. Proscar and Avodart workRead More ›

What We Should Have Learned About Prostate Cancer (PC) in the Past 10 Years: Part Two

Fri 30 May 2008

by Stephen B. Strum, MD, FACP Medical Oncologist and PCRI Co-founder Ashland, OR Edited from PCRI Insights May, 2008 v 11.2 Editor’s Note: In the Part 1, Dr. Strum illustrated his thesis, “what we should have learned about PC prevention”, with a case study of the Prostate Cancer Prevention Trial (PCPT). Explanation of High-Grade PCRead More ›

What We Should Have Learned About Prostate Cancer (PC) in the Past 10 Years

Wed 27 Feb 2008

  by Stephen B. Strum, MD, FACP Medical Oncologist and PCRI Co-founder Ashland, OR Edited from PCRI Insights February, 2008 v 11.1   Overview The goal for this article is to present my views on the current status of the everyday care of the PC patient. This communication thus serves as a State of theRead More ›

PCRI News – The Finasteride Controversy

Mon 16 Feb 2004

The Finasteride Controversy Monday, February 16, 2004 Last summer, a team of 16 researchers reported on the seven-year Prostate Cancer Prevention Trial study that followed almost 19,000 men. The article, entitled “The Influence of Finasteride on the Development of Prostate Cancer”, was published in the July 17, 2003 issue of The New England Journal ofRead More ›

Does Finasteride Alter the Pathology of the Prostate and Cancer Grading?

Sun 1 Feb 2004

By David G. Bostwick M.D., M.B.A., Bostwick Laboratories, Richmond, Virginia Reprinted from PCRI Insights February 2004 v7.1 Introduction One of the most important and popular forms of treatment for prostate cancer, androgen deprivation therapy (ADT), has been in use for more than 50 years. In the past two decades, new forms of androgen deprivation haveRead More ›